Jade Biosciences Reports Q3 GAAP EPS of -$0.42 and Strong Cash Position
Jade Biosciences (JBIO) has announced its third-quarter financial results, reporting a GAAP earnings per share (EPS) of -$0.42. Despite the quarterly loss, the company maintains a robust liquidity position with $475.7 million in cash, cash equivalents, and investments as of September 30, 2026. The company stated that its current capital reserves are sufficient to fund ongoing operating expenses based on existing business plans. This financial stability provides a runway for continued operations as the firm executes its strategic objectives.
Tickers: $JBIO
Topics: cash runway earnings report GAAP EPS
Read the full article at Seeking Alpha
Part of the story Vox Royalty Corp. Reports Q3 GAAP EPS of $0.03 and Strong Liquidity Position (2 articles)